Eaves, Alyssa C.
Teng, Chengwen http://orcid.org/0000-0001-9239-2125
Evoy, Kirk E. http://orcid.org/0000-0003-0913-7145
Frei, Christopher R. http://orcid.org/0000-0002-0692-4787
Funding for this research was provided by:
Actavis (TEF-IT-41)
National Center for Advancing Translational Sciences (UL1 TR002645)
Article History
Accepted: 13 June 2022
First Online: 15 July 2022
Declarations
:
: This work was supported by TEF-IT-41, an investigator-initiated grant to Dr. Frei’s institution, from Actavis Pharmaceuticals (formerly Forest and Allergan Pharmaceuticals). Dr. Frei was supported in part by an NIH Clinical and Translational Science Award (UL1 TR002645) during part of the time during which this study was conducted. This material is the result of work supported with resources and the use of facilities at the South Texas Veterans Health Care System. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the National Institutes of Health. The authors would like to thank student pharmacist Courtney Baus for her editorial assistance with the manuscript.
: This work was supported by TEF-IT-41, an investigator-initiated grant to Dr. Frei’s institution, from Actavis Pharmaceuticals (formerly Forest and Allergan Pharmaceuticals). Alyssa C. Eaves, Chengwen Teng, and Kirk E. Evoy declare no potential conflicts of interest or competing interests.
: The Institutional Review Board of the University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System Research and Development committee approved this study.
: Not applicable.
: All authors consent to the publication of this manuscript.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: The code that supports the findings of this study is available from the corresponding author upon reasonable request.
: Study concept and design: CRF. Statistical analysis: CRF. Interpretation of data: All authors. Drafting of the manuscript: ACE, CT, KEE, CRF. Critical revision of the manuscript for important intellectual content: All authors. Study supervision: CRF. All authors read and approved of the final version.